by Mike Barrett | Feb 8, 2016 | Employer Issues, Health Policy, Healthcare Issues, Healthcare Reform, Managed Care - Group Health, Pharmacy Costs, Pharmacy, PBMs and Pharma Costs, Providers, Uncategorized
We are finding some crazy Rx trends that are translating into real world cost and care issues for our clients and their employees. Here’s a prime example. We recently found that a type 2 diabetes drug (GLUMETZA) increased in cost by 900%, nearly overnight. After...
